- Home
- GDTC vs CMBM Comparison
GDTC vs CMBM Comparison
Compare GDTC & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- CMBM
- Stock Information
- Founded
- GDTC 2018
- CMBM 2011
- Country
- GDTC Singapore
- CMBM United States
- Employees
- GDTC N/A
- CMBM N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- GDTC Health Care
- CMBM Technology
- Exchange
- GDTC Nasdaq
- CMBM Nasdaq
- Market Cap
- GDTC 21.5M
- CMBM 25.0M
- IPO Year
- GDTC 2023
- CMBM 2019
- Fundamental
- Price
- GDTC $2.17
- CMBM $0.87
- Analyst Decision
- GDTC Buy
- CMBM Buy
- Analyst Count
- GDTC 1
- CMBM 1
- Target Price
- GDTC $5.00
- CMBM $3.00
- AVG Volume (30 Days)
- GDTC 21.1K
- CMBM 256.9K
- Earning Date
- GDTC 01-01-0001
- CMBM 11-06-2025
- Dividend Yield
- GDTC N/A
- CMBM N/A
- EPS Growth
- GDTC N/A
- CMBM N/A
- EPS
- GDTC N/A
- CMBM N/A
- Revenue
- GDTC $573,193.00
- CMBM $172,215,000.00
- Revenue This Year
- GDTC $5.37
- CMBM N/A
- Revenue Next Year
- GDTC N/A
- CMBM $17.73
- P/E Ratio
- GDTC N/A
- CMBM N/A
- Revenue Growth
- GDTC 63.03
- CMBM N/A
- 52 Week Low
- GDTC $1.65
- CMBM $0.23
- 52 Week High
- GDTC $4.05
- CMBM $1.69
- Technical
- Relative Strength Index (RSI)
- GDTC 62.97
- CMBM 52.16
- Support Level
- GDTC $1.95
- CMBM $0.79
- Resistance Level
- GDTC $2.30
- CMBM $1.07
- Average True Range (ATR)
- GDTC 0.09
- CMBM 0.10
- MACD
- GDTC 0.01
- CMBM -0.01
- Stochastic Oscillator
- GDTC 70.29
- CMBM 37.19
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.